New Key Statistics Module, Z-Score and F-Score
NAS:ANIK Key Ratios
Market Cap $ M | 382.98 |
Enterprise Value $ M | 339.15 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 23.01 |
Price/Book | 1.78 |
Price/Sales | 2.27 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 166.00 |
EPS (TTM) $ | -5.65 |
Beneish M-Score | -4.21 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -13.33 |
EV-to-EBITDA | -30.19 |
PEG | -- |
Shares Outstanding M | 14.85 |
Net Margin (%) | -49.60 |
Operating Margin % | -15.27 |
Pre-tax Margin (%) | -51.20 |
Quick Ratio | 3.76 |
Current Ratio | 5.26 |
ROA % (ttm) | -25.58 |
ROE % (ttm) | -31.32 |
ROIC % (ttm) | -10.60 |
Dividend Yield % | -- |
Altman Z-Score | 4.76 |
ANIK Number of Guru Trades
ANIK Volume of Guru Trades
Gurus Latest Trades with NAS:ANIK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ANIK is held by these investors
Total 1
Anika Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ANIK
Total 0- 1